# A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)

> **NCT02031991** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 102 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-06439535
- **BIOLOGICAL:** Avastin
- **BIOLOGICAL:** Avastin

## Key facts

- **NCT ID:** NCT02031991
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031991, "A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02031991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*